Hikma Pharmaceuticals PLC
HKMPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,339 | $5,094 | $4,222 | $6,616 |
| - Cash | $188 | $205 | $270 | $426 |
| + Debt | $1,306 | $1,191 | $1,283 | $846 |
| Enterprise Value | $6,457 | $6,080 | $5,235 | $7,036 |
| Revenue | $3,127 | $2,875 | $2,517 | $2,553 |
| % Growth | 8.8% | 14.2% | -1.4% | – |
| Gross Profit | $1,415 | $1,407 | $1,265 | $1,301 |
| % Margin | 45.3% | 48.9% | 50.3% | 51% |
| EBITDA | $787 | $791 | $691 | $705 |
| % Margin | 25.2% | 27.5% | 27.5% | 27.6% |
| Net Income | $359 | $190 | $188 | $421 |
| % Margin | 11.5% | 6.6% | 7.5% | 16.5% |
| EPS Diluted | 1.61 | 0.85 | 0.84 | 1.81 |
| % Growth | 89.4% | 1.2% | -53.6% | – |
| Operating Cash Flow | $564 | $608 | $530 | $638 |
| Capital Expenditures | -$165 | -$169 | -$138 | -$145 |
| Free Cash Flow | $399 | $439 | $392 | $493 |